Sawai Group (SWGHF) Stock Price, News & Analysis

Company Overview

Sawai Group (OTCMKTS:SWGHF) is a Japan‐based pharmaceutical company primarily focused on the development, manufacturing and marketing of generic medications. Established in 1975 and headquartered in Osaka, Sawai Group has grown to become one of the leading producers of oral solid dosage forms in the Japanese market. The company’s product portfolio includes tablets, capsules and other formulations for chronic and acute indications, with an emphasis on cost‐effective alternatives to branded therapies.

At the core of Sawai Group’s operations is a vertically integrated manufacturing network that encompasses research and development, quality control and commercial production. The company operates multiple GMP‐certified facilities across Japan, enabling it to manage the full lifecycle of a product—from formulation development and stability testing through large‐scale manufacturing and packaging. In addition to its own generics, Sawai Group offers contract manufacturing services to domestic and international pharmaceutical partners.

While the majority of Sawai Group’s revenue is generated in its home market, the company has pursued selective export opportunities and licensing agreements to extend its reach into other Asian countries. Its commercial organization includes regional sales offices and partnerships that support both ethical pharmaceutical channels and over‐the‐counter distribution. The executive leadership team, comprising professionals with deep experience in pharmaceutical science and commercial strategy, guides Sawai Group’s ongoing efforts to expand its product pipeline and enhance manufacturing capacity.

Key Stats

• Today's Range: $11.52 to $11.52
• 50-Day Range: $11.52 to $11.52
• 52-Week Range: $11.52 to $41.43
• Volume: N/A
• Average Volume: 1,700 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

SWGHF Stock Analysis - Frequently Asked Questions

How have SWGHF shares performed this year?

Sawai Group's stock was trading at $13.40 at the beginning of 2025. Since then, SWGHF stock has decreased by 14.0% and is now trading at $11.52.

When did Sawai Group's stock split?

Shares of Sawai Group split before market open on Monday, September 30th 2024.The 3-1 split was announced on Monday, September 30th 2024. The newly created shares were distributed to shareholders after the market closes on Monday, September 30th 2024. An investor that had 100 shares of stock prior to the split would have 300 shares after the split.

How do I buy shares of Sawai Group?

Shares of SWGHF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Today: 10/16/2025
• Next Earnings (Estimated): 11/14/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Drug Manufacturers - Specialty & Generic
• Sub-Industry: Pharmaceutical Products
• Current Symbol: OTCMKTS:SWGHF
• CIK: 1816901
• Web: www.sawaigroup.holdings
• Phone: 81-6-6105-5818
• Fax: N/A
• Employees: 3,393
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A